Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.43 USD | -1.01% | -0.70% | +12.22% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.22% | 377M | |
-6.42% | 84.57B | |
+3.95% | 39.93B | |
-26.37% | 27.93B | |
+52.09% | 24.21B | |
-6.59% | 17.17B | |
-32.37% | 13.93B | |
-10.45% | 12.3B | |
-15.88% | 11.84B | |
-2.85% | 7.91B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Barrington Adjusts Price Target on Anika Therapeutics to $48 From $44, Keeps Outperform Rating